RSPD

RSPD is in a Stage 2 advance with a corrective reset, supported by an intact higher high/lower low sequence and rising EMAs. Price is currently pulling back into the 9- and 20-EMA confluence above the 50-SMA, offering a favorable entry area. RSI and OB/OS readings remain neutral, indicating no exhaustion. Execution is to buy now on this pullback into structural support, with risk of rejection at the 200-DMA and invalidation below the EMA/50-SMA zone.

• ↑ETF AUM $5.2B offers broad exposure to consumer discretionary.
• ↑YTD performance up 7.75% amid improving consumer sentiment.
• ↓Morningstar assigns neutral rating, indicating no clear outperformance.